Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate

CHEBI:CHEBI_747026

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_name
CODEINE PHOSPHATE
rxcui
1431286
dea_schedule
CIII
active_ingredient_strength
300 mg/1
pharm_class
Xanthines [CS]
unii
GSL05Y1MN6
nui
M0023046
pharm_class_epc
Methylxanthine [EPC]
pharm_class_pe
Central Nervous System Stimulation [PE]
pharm_class_cs
Xanthines [CS]
manufacturer_name
Hikma Pharmaceuticals USA Inc.
spl_set_id
215e2a6f-ec32-4836-8fad-22c8b40ba1f1
upc
0300543000018
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
route
ORAL
marketing_category
NDA AUTHORIZED GENERIC
dosage_form
CAPSULE
labeler_name
Breckenridge Pharmaceutical, Inc.
package_marketing_start_date
20040610
generic_name
Butalbital, Acetaminophen, Caffeine and Codeine Phosphate
brand_name
Butalbital, Acetaminophen, Caffeine and Codeine Phosphate
brand_name_base
Butalbital, Acetaminophen, Caffeine and Codeine Phosphate
product_ndc
0054-3000
application_number
ANDA215138
marketing_start_date
20040610
spl_id
215e2a6f-ec32-4836-8fad-22c8b40ba1f1
package_ndc
0054-3000-01
package_description
100 CAPSULE in 1 BOTTLE (0054-3000-01)